Policy Statements

newscropped-CapAlliesLogoColor-23-e1411611145467.jpg

  • “We and the millions of Americans who support our organizations are deeply concerned that Senator Elizabeth Warren’s “Over the Counter Hearing Aid Act of 2017” is a bait-and-switch piece of legislation that will impose burdensome regulations, resulting in limited choice and higher prices for consumers. We are concerned that the House will allow a version of this legislation to be attached to the non-controversial Prescription Drug User Fee Act (PDUFA) legislation.Senator Warren’s legislation is misleading. Her proposal will increase regulation, pre-empt states, raise prices, and limit choice. It’s a solution looking for a problem. Physicians, healthcare professionals, patients, and consumers all lose under the Warren bill. We encourage Congress to oppose it at every turn.” 

    Read the Coalition letter HERE: Coalition Opposes Sen Warren’s crony Hearing Aid Bill_it’s bad for doctors, patients, and consumers May 2017

  • The Financial CHOICE Act is a market-based, common sense reform proposal that will peel back the most onerous Dodd-Frank regulatory layers. The legislation begins with a conservative consensus of eliminating the most damaging provisions of Dodd-Frank, explicitly reforming the Consumer Financial Protection Bureau (CFPB) and repealing the Durbin AmendmentCoalition Letter in Support of The Financial CHOICE Act of 2017 May 2017
  • Maryland consumers need more choices when it comes to their drugs, not fewer. HB 631 will drive those choices out of the marketplace, doing a disservice to Marylanders by limiting their options and driving pharmaceutical prices up and is therefore bad public policy:  Coalition Letter Opposed to Maryland House Bill 631 April 2017